COBISS Co-operative Online Bibliographic system & services COBISS
Melpomeni Fani
Personal bibliography for the period 2021-2023
2021
1.
FANI, Melpomeni, KOLENC, Petra, NOVAK, Doroteja, SIMONČIČ, Urban, et al. Selection
of the first ▫$\mathrm{^{99m}Tc}$▫-labelled somatostatin receptor subtype 2 antagonist for clinical translation-preclinical
assessment of two optimized candidates. Pharmaceuticals. Jan. 2021, vol. 14, art. no. 19, 15 str., ilustr. ISSN 1424-8247. DOI: 10.3390/ph14010019. [COBISS.SI-ID 47167747]
2022
2.
NOVAK, Doroteja, KOLENC, Petra, MANSI, Rosalba, GAONKAR, Raghuvir H., FANI, Melpomeni,
KROŠELJ, Marko, ANDERLUH, Marko. Breaking the paradigm : radiolabelled CCK2r antagonists
are superior to radiolabelled agonists in in vivo setting. In: Book of abstracts. [S. l.]: [s. n.], 2022. Str. 287, p357, ilustr. https://www.efmc-ismc.org/v2/data/1661849465EFMC-ISMC-Book-Web-HD3.pdf. [COBISS.SI-ID 121113859]
3.
NOVAK, Doroteja, KOLENC, Petra, MANSI, Rosalba, GAONKAR, Raghuvir H., FANI, Melpomeni,
KROŠELJ, Marko, ANDERLUH, Marko. Breaking the paradigm : radiolabelled CCK2r antagonists
are superior to radiolabelled agonists in in vivo setting. In: Book of abstracts. 2022. Str. 23, oc15, ilustr. https://www.ldorganisation.com/antfichiers/1661954691BoA-Web.pdf. [COBISS.SI-ID 121146627]
2023
4.
NOVAK, Doroteja, JANOTA, Barbara, HÖRMANN, Anton Amadeus, SAWICKA, Agnieszka, KROŠELJ,
Marko, HUBALEWSKA-DYDEJCZYK, Alicja, FANI, Melpomeni, MIKOLAJCZAK, Renata, KOLENC,
Petra, DECRISTOFORO, Clemens, GARNUSZEK, Piotr. Development of the 99mTc-labelled
SST2 antagonist TECANT-1 for a first-in-man multicentre clinical study. Pharmaceutics. [Online ed.]. 2023, vol. 15, iss. 3, art. 885, 16 str., ilustr. ISSN 1999-4923.
https://www.mdpi.com/1999-4923/15/3/885, Repository of the University of Ljubljana – RUL , DOI: 10.3390/pharmaceutics15030885. [COBISS.SI-ID 144626179]
project: ERAPERMED2018-125 Novel 99mTc-labelled somatostatin receptor antagonists in the diagnostic algorithm of neuroendocrine neoplasms—a feasibility study” (TECANT) [TECANT]; funder: ERA PerMed
project: I 4220-B; funder: Austrian Science Fund FWF
project: ERA-PerMed/01/2019; funder: National Centre for Research and Development
project: ERAPerMed/ 02/2019; funder: Jagiellonian University Medical College
project: C3330-19-522011 Razvoj inovativnega, z gama sevalcem tehnecijem-99m označenega antagonista somatostatinskih receptorjev za diagnostiko nevroendokrinih novotvorb - raziskava izvedljivosti [TECANT]; funder: National Centre for Nuclear Research, MIZS (Ministry of Education, Science and Sport)
project: ERAPERMED2018-125 Novel 99mTc-labelled somatostatin receptor antagonists in the diagnostic algorithm of neuroendocrine neoplasms—a feasibility study” (TECANT) [TECANT]; funder: ERA PerMed
project: I 4220-B; funder: Austrian Science Fund FWF
project: ERA-PerMed/01/2019; funder: National Centre for Research and Development
project: ERAPerMed/ 02/2019; funder: Jagiellonian University Medical College
project: C3330-19-522011 Razvoj inovativnega, z gama sevalcem tehnecijem-99m označenega antagonista somatostatinskih receptorjev za diagnostiko nevroendokrinih novotvorb - raziskava izvedljivosti [TECANT]; funder: National Centre for Nuclear Research, MIZS (Ministry of Education, Science and Sport)